Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial

PLoS One. 2020 Nov 5;15(11):e0240722. doi: 10.1371/journal.pone.0240722. eCollection 2020.

Abstract

Aims: Coronary microvascular dysfunction (CMD) carries a poor cardiovascular prognosis and may explain angina in women without obstructive coronary artery disease (CAD). Currently, no evidence-based treatment for CMD exists. We investigated whether reducing cardiovascular risk factors improves symptoms and microvascular function in women with non-endothelial dependent CMD and no obstructive CAD.

Methods: We randomized 62 women aged 40-75, with body mass index (BMI) >25 kg/m2, angina ≥monthly, and coronary flow velocity reserve (CFVR) ≤2.5 to a 24-week intervention comprising low energy diet, exercise training, and optimized treatment of hypertension, dyslipidemia and diabetes or to control. Patients were assessed before randomization and after 24 weeks. Primary outcomes were CFVR assessed by transthoracic Doppler stress-echocardiography and angina burden by Seattle Angina Questionnaire (SAQ). Secondary outcomes were exercise capacity, body composition, glycemic control, myocardial function, and anxiety and depression symptoms.

Results: Fifty-six participants (90%) completed the study. Median (IQR) age was 65.2 (57.1;70.7) years, BMI was 30.1 (28.4;32.7) kg/m2. The intervention resulted in relevant improvement in angina symptoms (9-21-point increase on SAQ-scales (all p<0.01)) but had no effect on CFVR (p = 0.468). Mean (CI) weight loss was 9.6 (7.80;11.48) kg, (p<0.0001). There was a significant mean (CI) decrease in depression symptoms = 1.16 (0.22;2.12), triglycerides = 0.52 (0.25;0.78) mmol/L, total cholesterol = 0.55 (0.12;0.98) mmol/L, and HbA1c in diabetics = 27.1 (1.60;52.6) mmol/mol but no effect on other secondary outcomes.

Conclusion: A major weight loss and intensified risk factor control resulted in significantly improved angina burden but no improvement of coronary microvascular function among women with microvascular angina.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Combined Modality Therapy / methods
  • Coronary Angiography
  • Coronary Circulation / physiology
  • Coronary Vessels / diagnostic imaging
  • Coronary Vessels / physiopathology
  • Diet, Reducing / methods*
  • Energy Intake / physiology
  • Exercise Therapy*
  • Female
  • Humans
  • Male
  • Microcirculation / physiology
  • Microvascular Angina / diagnosis
  • Microvascular Angina / etiology
  • Microvascular Angina / physiopathology
  • Microvascular Angina / therapy*
  • Middle Aged
  • Overweight / complications
  • Overweight / physiopathology
  • Overweight / therapy*
  • Pilot Projects
  • Risk Factors
  • Treatment Outcome
  • Weight Loss / physiology
  • Weight Reduction Programs / methods*

Grants and funding

This project received funding from the Capital Region of Denmark Research Foundation, Bispebjerg-Frederiksberg Hospital Internal Foundation, Eva og Henry Frænkels Memorial Foundation, Christensson-Cesons Family Foundation and Department of Cardiology Bispebjerg-Frederiksberg Hospital. This project received no grants from commercial sectors. Cambridge Weight Plan suppled the LED diet. No funders nor any persons related to the Cambridge Weight Plan played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript